Diagnosis of Pathological Complete Response by Minimal Invasive Biopsy After Neoadjuvant Chemotherapy in Breast Cancer

Clinical trial NCT02575612 · COMPLETED

Trial details

NCT number: NCT02575612
Sponsor: Heidelberg University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2014-07-01
Primary completion: 2015-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.